Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ImmuCell | ICCC | Nov 8, 2024 | 3.54 | +0.28 |
Immuneering A | IMRX | Nov 8, 2024 | 1.90 | -1.55 |
Immunic | IMUX | Nov 8, 2024 | 1.18 | 0.00 |
ImmunityBio | IBRX | Nov 8, 2024 | 5.57 | +5.09 |
Immunocore ADR | IMCR | Nov 8, 2024 | 34.69 | +1.11 |
Immunome | IMNM | Nov 8, 2024 | 12.98 | +3.51 |
ImmunoPrecise Antibodies | IPA | Nov 8, 2024 | 0.44 | 0.00 |
Immunovant | IMVT | Nov 8, 2024 | 30.65 | +2.41 |
Immutep ADR | IMMP | Nov 8, 2024 | 1.86 | +0.82 |
Imperial Oil | IMO | Nov 8, 2024 | 73.98 | 0.00 |
Imperial Petroleum | IMPP | Nov 8, 2024 | 3.59 | -1.91 |
Imperial Petroleum A Pref | IMPPP | Nov 8, 2024 | 24.89 | 0.00 |
Impinj | PI | Nov 8, 2024 | 203.56 | +0.28 |
Imunon | IMNN | Nov 8, 2024 | 0.80 | -2.63 |
IN8bio | INAB | Nov 8, 2024 | 0.34 | +3.93 |
Inari Medical | NARI | Nov 8, 2024 | 51.39 | -0.87 |
Incannex Healthcare ADR | IXHL | Nov 8, 2024 | 2.77 | +14.46 |
Inception Growth Acquisition | IGTA | Nov 8, 2024 | 11.37 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | Nov 8, 2024 | 11.41 | 0.00 |
Income Opportunity Realty Investors | IOR | Nov 8, 2024 | 16.50 | 0.00 |
Incyte | INCY | Nov 8, 2024 | 83.38 | +1.26 |
Indaptus Therapeutics | INDP | Nov 8, 2024 | 1.19 | 0.00 |
Independence Realty Trust | IRT | Nov 8, 2024 | 20.53 | 0.00 |
Independent Bank | IBCP | Nov 8, 2024 | 37.38 | +1.69 |
Independent Bank | INDB | Nov 8, 2024 | 72.09 | +2.10 |
Independent Bank Group | IBTX | Nov 8, 2024 | 65.17 | +1.42 |
India Bull 3X Direxion | INDL | Nov 8, 2024 | 66.02 | 0.00 |
India Consumer Egshares | INCO | Nov 8, 2024 | 68.26 | 0.00 |
India Earnings Wisdomtree | EPI | Nov 8, 2024 | 47.61 | 0.00 |
India Fund | IFN | Nov 8, 2024 | 17.99 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.